Skip to main content
NCBI home page
Annals of Surgery logoLink to Annals of Surgery
. 1988 May;207(5):569–580. doi: 10.1097/00000658-198805000-00011

Charity Hospital experience with long-term survival and prognostic factors in patients with breast cancer with localized or regional disease.

C M Sutherland 1, F J Mather 1
PMCID: PMC1493496  PMID: 3377567

Abstract

Long-term survival, the prognostic effects of race, age, tumor size, number of positive nodes, and presence of grave signs (fixation, peau d'orange/edema, dimpling/retraction, satellite nodules, and ulceration) in this distribution of estrogen receptors (ERs) and progesterone receptors (PRs) were studied in 2480 patients (1815 blacks, 665 whites) diagnosed with localized or regional breast cancer at Charity Hospital of Louisiana at New Orleans (CHNO) from 1948 to 1985 and followed up in the CHNO Tumor Registry. Breast cancer-specific survival rates were 57%, 45%, 41%, 39%, 38%, and 35% at 5, 10, 15, 20, 25, and 30 years, respectively. Size of tumor, clinical status of nodes, and degree of fixation were important prognostic clinical factors, and number of nodes was an important pathologic factor with no additional value of the "grave signs." Size and fixation were related. Independent of size, clinical and pathologic status and fixation were related. ER was related to age and PR was related to number of nodes. The excess mortality from breast cancer at later intervals from diagnoses was small compared with mortality from other causes. Some, but not all, clinical findings were important prognostic indicators. ER and PR were related to some variables with unclear meaning.

Full text

PDF
569

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Adair F., Berg J., Joubert L., Robbins G. F. Long-term followup of breast cancer patients: the 30-year report. Cancer. 1974 Apr;33(4):1145–1150. doi: 10.1002/1097-0142(197404)33:4<1145::aid-cncr2820330438>3.0.co;2-0. [DOI] [PubMed] [Google Scholar]
  2. Brinkley D., Haybrittle J. L. The curability of breast cancer. Lancet. 1975 Jul 19;2(7925):95–97. doi: 10.1016/s0140-6736(75)90003-3. [DOI] [PubMed] [Google Scholar]
  3. Clark G. M., McGuire W. L., Hubay C. A., Pearson O. H., Marshall J. S. Progesterone receptors as a prognostic factor in Stage II breast cancer. N Engl J Med. 1983 Dec 1;309(22):1343–1347. doi: 10.1056/nejm198312013092240. [DOI] [PubMed] [Google Scholar]
  4. Dayal H. H., Power R. N., Chiu C. Race and socio-economic status in survival from breast cancer. J Chronic Dis. 1982;35(8):675–683. doi: 10.1016/0021-9681(82)90020-0. [DOI] [PubMed] [Google Scholar]
  5. Duncan W., Kerr G. R. The curability of breast cancer. Br Med J. 1976 Oct 2;2(6039):781–783. doi: 10.1136/bmj.2.6039.781. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Ferguson D. J., Meier P., Karrison T., Dawson P. J., Straus F. H., Lowenstein F. E. Staging of breast cancer and survival rates. An assessment based on 50 years of experience with radical mastectomy. JAMA. 1982 Sep 17;248(11):1337–1341. [PubMed] [Google Scholar]
  7. Fisher B., Slack N. H., Bross I. D. Cancer of the breast: size of neoplasm and prognosis. Cancer. 1969 Nov;24(5):1071–1080. doi: 10.1002/1097-0142(196911)24:5<1071::aid-cncr2820240533>3.0.co;2-h. [DOI] [PubMed] [Google Scholar]
  8. Fisher E. R., Sass R., Fisher B. Pathologic findings from the National Surgical Adjuvant Project for Breast Cancers (protocol no. 4). X. Discriminants for tenth year treatment failure. Cancer. 1984 Feb 1;53(3 Suppl):712–723. doi: 10.1002/1097-0142(19840201)53:3+<712::aid-cncr2820531320>3.0.co;2-i. [DOI] [PubMed] [Google Scholar]
  9. Fisher E. R., Sass R., Fisher B. Pathologic findings from the national surgical adjuvant breast project. Correlations with concordant and discordant estrogen and progesterone receptors. Cancer. 1987 May 1;59(9):1554–1559. doi: 10.1002/1097-0142(19870501)59:9<1554::aid-cncr2820590904>3.0.co;2-b. [DOI] [PubMed] [Google Scholar]
  10. Fracchia A. A., Evans J. F., Eisenberg B. L. Stage III carcinoma of the breast. A detailed analysis. Ann Surg. 1980 Dec;192(6):705–710. doi: 10.1097/00000658-198012000-00002. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Langlands A. O., Pocock S. J., Kerr G. R., Gore S. M. Long-term survival of patients with breast cancer: a study of the curability of the disease. Br Med J. 1979 Nov 17;2(6200):1247–1251. doi: 10.1136/bmj.2.6200.1247. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. McBride C. M., Brown B. W., Thompson J. R., Westbrook K. C., Milne C. A. Can patients with breast cancer be cured of their disease? A sample of the M. D. anderson Hospital experience. Cancer. 1983 Mar 1;51(5):938–945. doi: 10.1002/1097-0142(19830301)51:5<938::aid-cncr2820510529>3.0.co;2-8. [DOI] [PubMed] [Google Scholar]
  13. Mueller C. B., Ames F., Anderson G. D. Breast cancer in 3,558 women: age as a significant determinant in the rate of dying and causes of death. Surgery. 1978 Feb;83(2):123–132. [PubMed] [Google Scholar]
  14. Nemoto T., Vana J., Bedwani R. N., Baker H. W., McGregor F. H., Murphy G. P. Management and survival of female breast cancer: results of a national survey by the American College of Surgeons. Cancer. 1980 Jun 15;45(12):2917–2924. doi: 10.1002/1097-0142(19800615)45:12<2917::aid-cncr2820451203>3.0.co;2-m. [DOI] [PubMed] [Google Scholar]
  15. Rao D. V., Bedwinek J., Perez C., Lee J., Fineberg B. Prognostic indicators in stage III and localized stage IV breast cancer. Cancer. 1982 Nov 15;50(10):2037–2043. doi: 10.1002/1097-0142(19821115)50:10<2037::aid-cncr2820501012>3.0.co;2-b. [DOI] [PubMed] [Google Scholar]
  16. Rubens R. D., Armitage P., Winter P. J., Tong D., Hayward J. L. Prognosis in inoperable stage III carcinoma of the breast. Eur J Cancer. 1977 Aug;13(8):805–811. doi: 10.1016/0014-2964(77)90134-7. [DOI] [PubMed] [Google Scholar]
  17. Say C. C., Donegan W. L. Invasive carcinoma of the breast: prognostic significance of tumor size and involved axillary lymph nodes. Cancer. 1974 Aug;34(2):468–471. doi: 10.1002/1097-0142(197408)34:2<468::aid-cncr2820340235>3.0.co;2-x. [DOI] [PubMed] [Google Scholar]
  18. Stanford J. L., Szklo M., Brinton L. A. Estrogen receptors and breast cancer. Epidemiol Rev. 1986;8:42–59. doi: 10.1093/oxfordjournals.epirev.a036295. [DOI] [PubMed] [Google Scholar]
  19. Sutherland C. M., Mather F. J. Long-term survival and prognostic factors in breast cancer patients with localized (no skin, muscle, or chest wall attachment) disease with and without positive lymph nodes. Cancer. 1986 Feb 1;57(3):622–629. doi: 10.1002/1097-0142(19860201)57:3<622::aid-cncr2820570338>3.0.co;2-c. [DOI] [PubMed] [Google Scholar]
  20. Sutherland C. M., Mather F. J. Long-term survival and prognostic factors in patients with regional breast cancer (skin, muscle, and/or chest wall attachment). Cancer. 1985 Mar 15;55(6):1389–1397. doi: 10.1002/1097-0142(19850315)55:6<1389::aid-cncr2820550638>3.0.co;2-b. [DOI] [PubMed] [Google Scholar]
  21. Young J. L., Jr, Ries L. G., Pollack E. S. Cancer patient survival among ethnic groups in the United States. J Natl Cancer Inst. 1984 Aug;73(2):341–352. doi: 10.1093/jnci/73.2.341. [DOI] [PubMed] [Google Scholar]
  22. Zucali R., Uslenghi C., Kenda R., Bonadonna G. Natural history and survival of inoperable breast cancer treated with radiotherapy and radiotherapy followed by radical mastectomy. Cancer. 1976 Mar;37(3):1422–1431. doi: 10.1002/1097-0142(197603)37:3<1422::aid-cncr2820370325>3.0.co;2-y. [DOI] [PubMed] [Google Scholar]

Articles from Annals of Surgery are provided here courtesy of Lippincott, Williams, and Wilkins

RESOURCES